Oncologic Outcome after Cessation or Dose Reduction of Capecitabine in Patients with Colon Cancer

PURPOSE: Oral capecitabine has been used as adjuvant therapy for colorectal cancer patients since the 1990s. Patient-initiated cessation or reduced use of capecitabine occurs widely for various reasons, yet the consequences of these actions are unclear. The present study sought to clarify treatment...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Yun, Jung-A, Kim, Hee Cheol, Son, Hyun-Sook, Kim, Hyoung Ran, Yun, Hae Ran, Cho, Yong Beom, Yun, Seong Hyeon, Lee, Woo Yong, Chun, Ho-Kyung
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Coloproctology 2010
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2998011/
https://ncbi.nlm.nih.gov/pubmed/21152231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3393/jksc.2010.26.4.287
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky